All Stories

  1. Novel Pullulan Bioconjugate for Selective Breast Cancer Bone Metastases Treatment
  2. A novel soluble supramolecular system for sustained rh-GH delivery
  3. Synthesis and characterization of variable conformation pH responsive block co-polymers for nucleic acid delivery and targeted cell entry
  4. Sub-unit vaccine against S. aureus-mediated infections: Set-up of nano-sized polymeric adjuvant
  5. pH-responsive lipid core micelles for tumour targeting
  6. Novel pH-responsive nanovectors for controlled release of ionisable drugs
  7. A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation
  8. pH-responsive poly(4-hydroxybenzoyl methacrylates) – design and engineering of intelligent drug delivery nanovectors
  9. Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
  10. Self assembling nanocomposites for protein delivery: Supramolecular interactions of soluble polymers with protein drugs
  11. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization
  12. Self‐assembling nanocomposites for protein delivery: Supramolecular interactions between PEG‐cholane and rh‐G‐CSF
  13. Star-Like Oligo-Arginyl-Maltotriosyl Derivatives as Novel Cell-Penetrating Enhancers for the Intracellular Delivery of Colloidal Therapeutic Systems
  14. Corrigendum to “Folate-mediated targeting of polymeric conjugates of gemcitabine” [Int. J. Pharm. 307 (2006) 258–269]
  15. Targeted Delivery of Small and Macromolecular Drugs. Edited by Ajit S. Narang and Ram I. Mahato.
  16. Proteins conjugation with ZnO sol–gel nanopowders
  17. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery
  18. Polymer control of ligand display on gold nanoparticles for multimodal switchable cell targeting
  19. Peptide and Protein Bioconjugation
  20. pH-sensitive PEG-based micelles for tumor targeting
  21. Production of lipid microparticles containing bioactive molecules functionalized with PEG
  22. Supramolecular Bioconjugates for Protein and Small Drug Delivery
  23. In Situ Growth of Side-Chain PEG Polymers from Functionalized Human Growth Hormone—A New Technique for Preparation of Enhanced Protein−Polymer Conjugates
  24. Targeting Glioma Cells in Vitro with Ascorbate-Conjugated Pharmaceutical Nanocarriers
  25. Polysaccharide-Based Anticancer Prodrugs
  26. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation
  27. Tailored PEG for rh-G-CSF Analogue Site-Specific Conjugation
  28. Production of Solid Lipid Submicron Particles for Protein Delivery Using a Novel Supercritical Gas‐Assisted Melting Atomization Process
  29. Cell up-take control of gold nanoparticles functionalized with a thermoresponsive polymer
  30. Absorption and Metabolism of Resveratrol Carboxyesters and Methanesulfonate by Explanted Rat Intestinal Segments
  31. Site-selective protein glycation and PEGylation
  32. Doxorubicin coupled to lactosaminated albumin: Effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats
  33. Cyclodextrin/PEG based hydrogels for multi-drug delivery
  34. Avidin bioconjugate with a thermoresponsive polymer for biological and pharmaceutical applications
  35. New cyclodextrin bioconjugates for active tumour targeting
  36. Custom-Tailored Pharmacokinetics and Pharmacodynamics via Chemical Modifications of Biotech Drugs
  37. Histaminase PEGylation: Preparation and characterization of a new bioconjugate for therapeutic application
  38. Nanotechnologies in Protein Delivery
  39. Folate-mediated targeting of polymeric conjugates of gemcitabine
  40. Preparation and characterization of active site protected poly(ethylene glycol)–avidin bioconjugates
  41. Temperature-Sensitive Hydrogels
  42. Glycosilated Macromolecular Conjugates of Antiviral Drugs with a Polyaspartamide
  43. Nisin-loaded poly-l-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity
  44. Specific Antitumor Targetable β-Cyclodextrin−Poly(ethylene Glycol)−Folic Acid Drug Delivery Bioconjugate
  45. Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug
  46. Pharmacokinetics of pegylated interferons: What is misleading?
  47. Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques
  48. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation
  49. Thermodynamic Analysis of Micronization Processes from Gas-Saturated Solution
  50. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
  51. Synthesis and Physicochemical Characterization of Folate−Cyclodextrin Bioconjugate for Active Drug Delivery
  52. Poly(hydroxyethylaspartamide) derivatives as colloidal drug carrier systems
  53. Poly(ethylene glycol)–avidin bioconjugates: suitable candidates for tumor pretargeting
  54. Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
  55. Prevention of Muscle and Nerve Damage after a Prolonged Ischemia/Reperfusion Syndrome: An Experimental Animal Model
  56. Production of Insulin‐Loaded Poly(Ethylene Glycol)/Poly(l‐Lactide) (PEG/PLA) Nanoparticles by Gas Antisolvent Techniques
  57. Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers
  58. Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation
  59. Immunological Properties of Uricase Conjugated to Neutral Soluble Polymers
  60. Controlled release of biomolecules from temperature-sensitive hydrogels prepared by radiation polymerization
  61. Pre-Targeted Locoregional Radioimmunotherapy with 90 Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic Results
  62. Production of Protein-Loaded Polymeric Microcapsules by Compressed CO 2 in a Mixed Solvent
  63. New PEGs for Peptide and Protein Modification, Suitable for Identification of the PEGylation Site
  64. Polyphosphazene microspheres for insulin delivery
  65. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine)
  66. Poly (acryloyl-l-proline methyl ester) hydrogels obtained by radiation polymerization for the controlled release of drugs
  67. Biopharmaceutical Properties of Uricase Conjugated to Neutral and Amphiphilic Polymers
  68. Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins
  69. Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery
  70. Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release
  71. New Synthetic Polymers for Enzyme and Liposome Modification
  73. Enhanced biocompatibility of polyphosphazenes achieved by radiation grafting
  74. Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly( ethylene glycol)
  75. Anti-inflammatory Activity of Polyphosphazene-based Naproxen Slow-release Systems
  76. Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride
  77. Covalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applications
  78. New Synthetic Amphiphilic Polymers for Steric Protection of Liposomes in Vivo
  79. Synthesis and molecular weight characterization of end-functionalized N-vinyl-2-pyrrolidone oligomers
  80. Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis
  81. A Branched Monomethoxypoly(ethylene glycol) for Protein Modification
  82. Biodistribution of a polyethylene glycol-modified superoxide dismutase in mice and its effect on myocardial ischemia treatment in rats
  83. Synthesis and molecular weight characterization of low molecular weight end-functionalized poly(4-acryloylmorpholine)
  84. Low Molecular Weight End-Functionalized Poly(N-Vinylpyrrolidinone) for the Modification of Polypeptide Aminogroups
  85. Radiation grafting of hydrophilic monomers onto poly[bis(trifluoroethoxy)phosphazene]
  86. P179 distribution of nativ superoxide dismutase and its monomethoxy (polyethylene glycol) (mPEG) modification into the rat lymphatic system
  87. Preservation of Thrombolytic Activity of Urokinase Modified with Monomethoxypoly(ethylene glycol
  88. Radiation grafting of hydrophilic monomers onto polyphosphazenes and assessment of the biocompatibility of the modified samples
  89. Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity
  90. Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity
  91. Hydrogels obtained by radiation-induced polymerization as delivery systems for peptide and protein drugs
  92. Polyphosphazenes as biomaterials: surface modification of poly(bis(trifluoroethoxy)phosphazene) with polyethylene glycols
  93. Active Site Protection of Proteolytic Enzymes by Poly(ethylene glycol) Surface Modification
  94. Fast atom bombardment in the structural identification of intermediates in the hydrolytic degradation of polyphosphazenes
  95. Desferrioxamine potentiated SOD antiinflammatory activity in rat adjuvant arthritis: Role of iron and bacterial toxins
  96. Desferrioxamine potentiated SOD antiinflammatory activity in rat adjuvant arthritis: Role of iron and bacterial toxins
  97. Preparation and Properties of Monomethoxypoly(Ethylene Glycol)-Modified Enzymes for Therapeutic Applications
  98. Accurate evaluation method of the polymer content in Monomethoxy(polyethylene glycol) modified proteins based on Amino acid analysis
  99. Slow release of narciclasine from matrices obtained by radiation-induced polymerization
  100. Biocompatible polyphosphazenes by radiation-induced graft copofymerization and heparinization
  101. Enzyme modification by MPEG with an amino acid or peptide as spacer arms
  102. Determination of narciclasine in serum by reversed-phase high-performance liquid chromatography: comparison of amperometric, ultraviolet photometric and fluorescence detection
  103. Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats
  104. A Comparative Study of Enzymatic, Structural, and Pharmacokinetic Properties of Superoxide Dismutase Isolated from Two Sources and Modified by Monomethoxypolyethylene Glycol Using Different Methods of Coupling
  105. Spectroscopic characterization of polyethyleneglycol modified superoxide dismutase: 1H NMR studies on its Cu2Co2 derivative
  106. Effects of monomethoxypoly(ethylene glycol) modification of ribonuclease on antibody recognition, substrate accessibility and conformational stability
  107. Hydroxyt-Terminated Polyvinylpyrrolidone for the Modification of Polypeptides
  108. Radiation-induced graft copolymerization of hydrophilic monomers onto polyphosphazenes
  109. Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase
  110. Arginase Immobilization on Poly(hydroxyethyl acrylate) Matrix Beads
  111. Current development of analytical affinity chromatography: Design and biotechnological uses of molecular recognition surfaces
  112. Molecular diagnostics using analytical immuno high performance liquid affinity chromatography
  113. Drug Delivery Systems
  114. Bioconjugation and Biodistribution